PMC:3220857 / 1514-1753 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3220857","sourcedb":"PMC","sourceid":"3220857","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3220857","text":"CONCLUSIONS\nThe marked decrease in hepatic TG content induced by a 16-week VLCD is accompanied by a decrease in plasma CETP concentration and an increase in apoAI levels, without improving the cholesterol efflux properties of HDL in vitro.","divisions":[{"label":"title","span":{"begin":0,"end":11}}],"tracks":[]}